BCL2L1 and cancer: As summarized in Figure 7E, this study demonstrated a VNR-resistant strategy in lung adenocarcinoma cells, by which an increase GCS expression caused anti-apoptotic Bcl-xL up-regulation to facilitate cancer cell survival in response to VNR treatment.